Cargando…
Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
PURPOSE: The aim of this study was to determine the long-term safety of drug-eluting stent (DES) versus bare metal stent (BMS) implantation in a “real-world” setting. PATIENTS AND METHODS: A total of 1809 patients who were treated with implantation of either BMS or DES were assessed. Kaplan-Meier an...
Autores principales: | Vogt, Alexander, Schoelmerich, Anke, Pollner, Franziska, Schlitt, Manuela, Raaz, Uwe, Maegdefessel, Lars, Reindl, Iris, Buerke, Michael, Werdan, Karl, Schlitt, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237098/ https://www.ncbi.nlm.nih.gov/pubmed/22174579 http://dx.doi.org/10.2147/VHRM.S24370 |
Ejemplares similares
-
Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects
por: Maegdefessel, Lars, et al.
Publicado: (2009) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013) -
Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019) -
Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013) -
Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)